| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | FI | PI | | Oxis 6 Turbuhaler | 60 Einzeldosen | 22.68 | 42.45 | 10% | | Inhalationspulver: Formoteroli Fumaras Dihydricus 6 µg | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Oxis 12 Turbuhaler | 60 Einzeldosen | 29.72 | 50.50 | 10% | | Inhalationspulver: Formoteroli Fumaras Dihydricus 12 µg | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Foradil 12 mcg | 60 Kapsel(n) | 27.21 | 47.65 | 10% | | Trockenpulver-Kapseln zur Inhalation: Formoteroli Fumaras Dihydricus 12 µg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
| | FI | PI | PS | Onbrez Breezhaler 150 mcg | 30 Kapsel(n) | 36.21 | 57.95 | 10% | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | PS | Onbrez Breezhaler 300 mcg | 30 Kapsel(n) | 42.47 | 65.15 | 10% | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | PS | Onbrez Breezhaler 150 mcg | 90 Kapsel(n) | 92.33 | 122.40 | 10% | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | PS | Onbrez Breezhaler 300 mcg | 90 Kapsel(n) | 108.32 | 140.75 | 10% | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | PS | Onbrez Breezhaler 150 mcg | 90 Kapsel(n) | PA | PA | k.A. | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Wirkstoffe | Novartis Pharma Schweiz AG | B | FB | | G |  |
| | FI | PI | PS | Onbrez Breezhaler 300 mcg | 90 Kapsel(n) | PA | PA | k.A. | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Wirkstoffe | Novartis Pharma Schweiz AG | B | FB | | G |  |
|
| | FI | PI | | Vannair 100/6 | 120 Einzeldosen | 42.16 | 64.80 | 10% | | Dosier-Aerosol: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Vannair 200/6 | 120 Einzeldosen | 47.90 | 71.40 | 10% | | Dosier-Aerosol: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Symbicort 100/6 Turbuhaler | 60 Einzeldosen | 22.40 | 42.10 | 10% | | Inhalationspulver: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Symbicort 100/6 Turbuhaler | 120 Einzeldosen | 39.38 | 61.60 | 10% | | Inhalationspulver: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Symbicort 200/6 Turbuhaler | 60 Einzeldosen | 25.44 | 45.60 | 10% | | Inhalationspulver: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Symbicort 200/6 Turbuhaler | 120 Einzeldosen | 44.74 | 67.75 | 10% | | Inhalationspulver: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Symbicort 400/12 Turbuhaler | 60 Einzeldosen | 40.84 | 63.30 | 10% | | Inhalationspulver: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G |  |
|
| | FI | PI | | Foster | 120 | 48.00 | 71.50 | 10% | | Solution pour inhalation en flacon pressurisé: 2 Wirkstoffe | Chiesi SA | B / SL | FB | | G |  |
| | FI | PI | | Foster | 240 | PA | PA | k.A. | | Solution pour inhalation en flacon pressurisé: 2 Wirkstoffe | Chiesi SA | B | FB | | G |  |
|
| | FI | PI | PS | Flutiform 50/5 | 120 | 30.89 | 51.85 | 10% | | Dosier-Aerosol: 2 Wirkstoffe | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
| | FI | PI | PS | Flutiform 125/5 | 120 | 41.27 | 63.80 | 10% | | Dosier-Aerosol: 2 Wirkstoffe | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
| | FI | PI | PS | Flutiform 250/10 | 120 | 58.69 | 83.80 | 10% | | Dosier-Aerosol: 2 Wirkstoffe | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | | G |  |
|
| | FI | | | Atectura Breezhaler 150/80 μg | 30 | 33.36 | 54.70 | 10% | | Inhalationspulver: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | | | Atectura Breezhaler 150/80 μg | 90 | 99.99 | 131.20 | 10% | | Inhalationspulver: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | | | Atectura Breezhaler 150/160 μg | 30 | 33.36 | 54.70 | 10% | | Inhalationspulver: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | | | Atectura Breezhaler 150/160 μg | 90 | 99.99 | 131.20 | 10% | | Inhalationspulver: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | | | Atectura Breezhaler 150/320 μg | 30 | 33.36 | 54.70 | 10% | | Inhalationspulver: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | | | Atectura Breezhaler 150/320 μg | 90 | 99.99 | 131.20 | 10% | | Inhalationspulver: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
| | FI | PI | | Berodual N | 200 Inhalation(en) | 12.21 | 26.30 | 10% | | Dosier-Aerosol: 2 Wirkstoffe | Boehringer Ingelheim (Schweiz) GmbH | B / SL | FB | | G |  |
|
| | FI | PI | PS | Ultibro Breezhaler 110/50 | 30 Kapsel(n) | 48.66 | 72.25 | 10% | | Inhalationspulver: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | PS | Ultibro Breezhaler 110/50 | 90 | 145.82 | 183.80 | 10% | | Inhalationspulver: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
L | | FI | PI | | Trimbow | 120 | 62.32 | 87.95 | 10% | | solution pour inhalation en flacon pressurisé: 3 Wirkstoffe | Chiesi SA | B / SL | FB | | G |  |
L | | FI | PI | | Trimbow | 360 | 186.96 | 231.05 | 10% | | solution pour inhalation en flacon pressurisé: 3 Wirkstoffe | Chiesi SA | B / SL | FB | | G |  |
| | FI | PI | | Trimbow | 60 | PA | PA | k.A. | | solution pour inhalation en flacon pressurisé: 3 Wirkstoffe | Chiesi SA | B | FB | | G |  |
|
| | FI | PI | | Trixeo Aerosphere 5/7.2/160 μg | 56 | PA | PA | k.A. | | | AstraZeneca AG | B | FB | | G |  |
| | FI | PI | | Trixeo Aerosphere 5/7.2/160 μg | 120 | PA | PA | k.A. | | | AstraZeneca AG | B | FB | | G |  |
| | FI | PI | | Trixeo Aerosphere 5/7.2/160 μg | 360 | PA | PA | k.A. | | | AstraZeneca AG | B | FB | | G |  |
|
L | | FI | PI | | Enerzair Breezhaler 150/50/160 μg | 30 | 70.11 | 96.90 | 10% | | | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
L | | FI | PI | | Enerzair Breezhaler 150/50/160 μg | 30 | 70.11 | 96.90 | 10% | | | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
L | | FI | PI | | Enerzair Breezhaler 150/50/160 μg | 90 | 210.42 | 257.95 | 10% | | | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
| | FI | PI | | Qvar Autohaler 100 µg | 200 Inhalation(en) | 20.00 | 39.35 | 10% | | Dosier-Aerosol: Beclometasoni Dipropionas 100 µg | Teva Pharma AG | B / SL | FB | | G |  |
| | FI | PI | | Beclo Orion Easyhaler | 200 | 29.48 | 50.20 | 10% | | Inhalationspulver: Beclometasoni Dipropionas 200 µg | Orion Pharma AG | B / SL | FB | | G |  |
| | FI | PI | | Qvar Autohaler 50 µg | 100 Inhalation(en) | PA | PA | k.A. | | Dosier-Aerosol: Beclometasoni Dipropionas 50 µg | Teva Pharma AG | B | FB | | G |  |
| | FI | PI | | Qvar Autohaler 50 µg | 200 Inhalation(en) | PA | PA | k.A. | | Dosier-Aerosol: Beclometasoni Dipropionas 50 µg | Teva Pharma AG | B | FB | | G |  |
| | FI | PI | | Qvar Autohaler 100 µg | 100 Inhalation(en) | PA | PA | k.A. | | Dosier-Aerosol: Beclometasoni Dipropionas 100 µg | Teva Pharma AG | B | FB | | G |  |
|
| | FI | PI | | Pulmicort Respules 0,25 mg/mL | 20 1 Ampulle(n) à 2 ml | 21.29 | 40.85 | 10% | | Suspension: Budesonidum | AstraZeneca AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Pulmicort Respules 0,5 mg/mL | 20 1 Ampulle(n) à 2 ml | 39.32 | 61.55 | 10% | | Suspension: Budesonidum | AstraZeneca AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Miflonide Breezhaler 200 mcg | 60 | 11.76 | 25.80 | 10% | | Inhalationspulver: Budesonidum 200 µg | Novartis Pharma Schweiz AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Miflonide Breezhaler 400 mcg | 60 | 23.52 | 43.40 | 10% | | Inhalationspulver: Budesonidum 400 µg | Novartis Pharma Schweiz AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Budenid Steri-Nebs 0.5mg/2ml | 20 Stück | 15.37 | 34.05 | 10% | | Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum | Teva Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Budenid Steri-Nebs 1mg/2ml | 20 Stück | 29.96 | 50.80 | 10% | | Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum | Teva Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Pulmicort Turbuhaler 100 | 200 Einzeldosen | 16.90 | 35.80 | 10% | | Inhalationspulver: Budesonidum 100 µg | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Pulmicort Turbuhaler 200 | 200 Einzeldosen | 33.78 | 55.20 | 10% | | Inhalationspulver: Budesonidum 200 µg | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Pulmicort Turbuhaler 400 | 50 Einzeldosen | 16.90 | 35.80 | 10% | | Inhalationspulver: Budesonidum 400 µg | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Pulmicort Respules 0,125 mg/mL | 20 1 Ampulle(n) à 2 ml | 16.82 | 35.70 | 10% | | Suspension: Budesonidum | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Budenid Steri-Nebs 0.5mg/2ml | 60 Stück | PA | PA | k.A. | | Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum | Teva Pharma AG | B | FB | | G |  |
| | FI | PI | | Budenid Steri-Nebs 1mg/2ml | 60 Stück | PA | PA | k.A. | | Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum | Teva Pharma AG | B | FB | | G |  |
|
| | FI | PI | | Axotide 0,050 mg | Inhalation(en) à 0.05 mg | 10.47 | 20.20 | 10% | | Dosier-Aerosol: Fluticasoni Propionas 50 µg | GlaxoSmithKline AG | ● B / SL | FB | | G |  |
| | FI | PI | | Axotide 0,125 mg | Inhalation(en) à 0.125 mg | 22.90 | 42.70 | 10% | | Dosier-Aerosol: Fluticasoni Propionas 125 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Axotide 0,250 mg | Inhalation(en) à 0.25 mg | 36.89 | 58.75 | 10% | | Dosier-Aerosol: Fluticasoni Propionas 250 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Axotide 100 ug | 60 Inhalation(en) | 9.34 | 18.90 | 10% | | | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Axotide 250 ug | 60 Inhalation(en) | 20.37 | 39.80 | 10% | | | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Axotide 500 ug | 60 Inhalation(en) | 32.42 | 53.60 | 10% | | | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Axotide Nebules 0,5 mg/2 mL | 10 Einzeldosen | 9.06 | 18.60 | k.A. | | gebrauchsfertige Suspension zur Inhalation: Fluticasoni-17 Propionas | GlaxoSmithKline AG | B | FB | | G |  |
| | FI | PI | | Axotide Nebules 2 mg/2 mL | 10 Einzeldosen | 32.80 | 54.05 | k.A. | | gebrauchsfertige Suspension zur Inhalation: Fluticasoni-17 Propionas 2 mg | GlaxoSmithKline AG | B | FB | | G |  |
|
| KFI | FI | PI | | Alvesco 80 ug | 120 Inhalation(en) | 22.26 | 41.95 | 10% | | Dosier-Aerosol: Ciclesonidum 80 µg | Covis Pharma GmbH | B / SL | FB | | G |  |
| KFI | FI | PI | | Alvesco 160 ug | 120 Inhalation(en) | 27.86 | 48.40 | 10% | | Dosier-Aerosol: Ciclesonidum 160 µg | Covis Pharma GmbH | B / SL | FB | | G |  |
| KFI | FI | PI | | Alvesco 80 ug | 60 Inhalation(en) | PA | PA | k.A. | | Dosier-Aerosol: Ciclesonidum 80 µg | Covis Pharma GmbH | B | FB | | G |  |
| KFI | FI | PI | | Alvesco 160 ug | 60 Inhalation(en) | PA | PA | k.A. | | Dosier-Aerosol: Ciclesonidum 160 µg | Covis Pharma GmbH | B | FB | | G |  |
|
| | FI | PI | | Arnuity Ellipta 90 mcg | 30 Einzeldosen | 15.60 | 34.30 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasonum Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 90 mcg | 3 x 30 | 46.80 | 70.15 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasonum Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 182 mcg | 30 Einzeldosen | 25.58 | 45.75 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasonum Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 182 mcg | 3 x 30 | 76.74 | 104.50 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasonum Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | | | Arnuity Ellipta 46 mcg | 30 | PA | PA | k.A. | | Einzeldosiertes Pulver zur Inhalation: Fluticasonum Furoas 46 µg | GlaxoSmithKline AG | B | FB | | G |  |
|
| | FI | PI | | Atrovent 250 mcg/2 ml | 60 Einzeldosen | 18.72 | 37.90 | 10% | | Inhalationslösung (Einzeldosen): Ipratropii Bromidum Anhydricum 250µg / 2ml | Boehringer Ingelheim (Schweiz) GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Atropair Steri-Nebs 0.25mg/1ml | 60 Einzeldosen | 10.53 | 20.30 | 10% | | Inhalationslösung: Ipratropii Bromidum Anhydricum 250 µg/ml | Teva Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Atropair Steri-Nebs 0.5mg/2ml | 60 Einzeldosen | 18.94 | 38.15 | 10% | | Inhalationslösung: Ipratropii Bromidum Anhydricum 500µg / 2ml | Teva Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Atrovent N | 200 Inhalation(en) | 10.28 | 20.00 | 10% | | Dosier-Aerosol: Ipratropii Bromidum 21 µg | Boehringer Ingelheim (Schweiz) GmbH | B / SL | FB | | G |  |
| | | PI | | Atrovent | 15 ml | 13.12 | 29.80 | k.A. | | Dosier-Aerosol: Ipratropii Bromidum 20 µg | Boehringer Ingelheim (Schweiz) GmbH | B | FB | | G |  |
|
| | FI | PI | PS | Seebri Breezhaler | 30 Kapsel(n) | 39.87 | 62.15 | 10% | | Mikrogramm: Glycopyrronium 50 µg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | PS | Seebri Breezhaler | 90 Kapsel(n) | 119.61 | 153.70 | 10% | | Mikrogramm: Glycopyrronium 50 µg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
| | FI | PI | | Gynipral | 5 1 Ampulle(n) à 2 ml | PA | 26.65 | 10% | | Injektionslösung: Hexoprenalini Sulfas 5 µg/ml | Takeda Pharma AG | B | FB | | G |  |
| | FI | PI | | Gynipral | 5 1 Ampulle(n) à 5 ml | PA | 42.95 | 10% | | Injektionslösung: Hexoprenalini Sulfas 5 µg/ml | Takeda Pharma AG | B | FB | | G |  |
|
| | FI | | | Aminophyllin Amino | 10 1 Ampulle(n) à 10 ml | PA | PA | k.A. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | FI | | | Escophyllin i.v. | 5 Ampulle(n) à 10 ml | 3.35 | 8.05 | k.A. | | Injektionslösung: Theophyllinum 190 mg | G. Streuli & Co. AG | B / SO | FB | | G |  |
| | FI | | | Escophyllin i.v. | 10 Ampulle(n) à 10 ml | PA | 13.35 | k.A. | | Injektionslösung: Theophyllinum 190 mg | G. Streuli & Co. AG | B | FB | | G |  |
| | FI | | | Escophyllin i.v. | 50 Ampulle(n) à 10 ml | PA | 44.45 | k.A. | | Injektionslösung: Theophyllinum 190 mg | G. Streuli & Co. AG | B | FB | | G |  |
| | FI | PI | | Phyllotemp Continus 225 | 60 Tablette(n) | 12.74 | 27.30 | k.A. | | Retard-Tabletten: Theophyllinum Et Ethylendiaminum 225 mg | Mundipharma Medical Company | B | FB | | G |  |
|
| | FI | PI | CM | Lukair 4 mg | 28 Tablette(n) | 19.25 | 38.50 | 10% | | Kautabletten: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | CM | Lukair 4 mg | 98 Tablette(n) | 67.48 | 93.85 | 10% | | Kautabletten: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | CM | Lukair 5 mg | 28 Tablette(n) | 19.25 | 38.50 | 10% | | Kautabletten: Montelukastum 5 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | CM | Lukair 5 mg | 98 Tablette(n) | 67.48 | 93.85 | 10% | | Kautabletten: Montelukastum 5 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | CM | Lukair 4 mg | 28 Sachet(s) | 20.59 | 40.05 | 20% | | Granulat: Montelukastum 4 mg | Organon GmbH | ● B / SL / SO | FB | | G |  |
| | FI | PI | | Singulair 4 mg | 28 Sachet(s) | 20.68 | 40.15 | 20% | | Granulat: Montelukastum 4 mg | Organon GmbH | ● B / SL / SO | FB | | G |  |
| | FI | PI | CM | Lukair 10 mg | 28 Tablette(n) | 19.25 | 38.50 | 10% | | Filmtabletten: Montelukastum 10 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | CM | Lukair 10 mg | 98 Tablette(n) | 67.48 | 93.85 | 10% | | Filmtabletten: Montelukastum 10 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Singulair | 28 Tablette(n) | 19.33 | 38.60 | 10% | | Filmtabletten: Montelukastum 10 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Singulair | 98 Tablette(n) | 67.48 | 93.85 | 10% | | Filmtabletten: Montelukastum 10 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Singulair 5 mg | 28 Tablette(n) | 19.33 | 38.60 | 10% | | Kautabletten für Kinder: Montelukastum 5 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Singulair 5 mg | 98 Tablette(n) | 67.48 | 93.85 | 10% | | Kautabletten für Kinder: Montelukastum 5 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Singulair 4 mg | 28 Tablette(n) | 19.32 | 38.60 | 10% | | Kautabletten für Kleinkinder: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Singulair 4 mg | 98 Tablette(n) | 67.45 | 93.85 | 10% | | Kautabletten für Kleinkinder: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Montelukast Sandoz 4 mg | 28 Tablette(n) | 17.57 | 36.55 | 10% | | Kautabletten: Montelukastum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Sandoz 4 mg | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Kautabletten: Montelukastum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Sandoz 5 mg | 28 Tablette(n) | 17.57 | 36.55 | 10% | | Kautabletten: Montelukastum 5 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Sandoz 5 mg | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Kautabletten: Montelukastum 5 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Spirig HC 4 | 28 Tablette(n) | 17.58 | 36.60 | 10% | | Kautabletten: Montelukastum 4 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Spirig HC 4 | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Kautabletten: Montelukastum 4 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Spirig HC 5 | 28 Tablette(n) | 17.58 | 36.60 | 10% | | Kautabletten: Montelukastum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Spirig HC 5 | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Kautabletten: Montelukastum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast-Mepha 4 mg | 28 Tablette(n) | 17.57 | 36.55 | 10% | | Kautabletten: Montelukastum 4 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast-Mepha 4 mg | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Kautabletten: Montelukastum 4 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast-Mepha 5 mg | 28 Tablette(n) | 17.57 | 36.55 | 10% | | Kautabletten: Montelukastum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast-Mepha 5 mg | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Kautabletten: Montelukastum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Sandoz 4 | 28 Sachet(s) | 17.57 | 36.55 | 10% | | Granulat: Montelukastum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast-Mepha 4 | 28 Stück | 17.57 | 36.55 | 10% | | Granulat: Montelukastum 4 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Helvepharm 10 mg | 28 Tablette(n) | 17.48 | 36.45 | 10% | | Filmtabletten: Montelukastum 10 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Helvepharm 10 mg | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Filmtabletten: Montelukastum 10 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Sandoz 10 mg | 28 Tablette(n) | 17.57 | 36.55 | 10% | | Filmtabletten: Montelukastum 10 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Sandoz 10 mg | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Filmtabletten: Montelukastum 10 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast-Mepha 10 mg | 28 Tablette(n) | 17.57 | 36.55 | 10% | | Filmtabletten: Montelukastum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast-Mepha 10 mg | 98 Tablette(n) | 61.35 | 86.85 | 10% | | Filmtabletten: Montelukastum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Montelukast Spirig HC 10 | 30 | PA | PA | k.A. | | Filmtabletten: Montelukastum 10 mg | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Montelukast Spirig HC 10 | 100 | PA | PA | k.A. | | Filmtabletten: Montelukastum 10 mg | Spirig HealthCare AG | B | FB | | G |  |
|
L | | FI | | | Nucala 100 mg | | 1229.29 | 1409.70 | 10% | | Lyophilisat: Mepolizumabum 100 mg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | PI | | Nucala 100 mg/mL | | 1229.29 | 1409.70 | 10% | | Injektionslösung im Fertigpen: Mepolizumabum 100mg / 1ml | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | PI | | Nucala 100 mg/mL | 3 x 1 | 3687.87 | 4026.05 | 10% | | Injektionslösung im Fertigpen: Mepolizumabum 100mg / 1ml | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | | | Nucala 100 mg/mL | | 1229.29 | 1409.70 | 10% | | Injektionslösung in der Fertigspritze: Mepolizumabum 100mg / 1ml | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | | | Nucala 100 mg/mL | 3 x 1 | PA | PA | k.A. | | Injektionslösung in der Fertigspritze: Mepolizumabum 100mg / 1ml | GlaxoSmithKline AG | B | FB | | G |  |
|
L | | FI | PI | | Fasenra | | 2319.39 | 2605.30 | 10% | | Injektionslösung: Benralizumabum 30 mg/ml | AstraZeneca AG | B / SL | FB | | G |  |
L | | FI | PI | | Fasenra Pen 30 mg /1 ml | | 2319.39 | 2605.30 | 10% | | lnjektionslösung: Benralizumabum 30 mg/ml | AstraZeneca AG | B / SL | FB | | G |  |
|
| | | PI | H | Regenaplex Nr. 24c | 15 ml | PA | PA | k.A. | | Tropfen zum Einnehmen: 10 Wirkstoffe | Regena AG | D | FB | | G |  |
| | | PI | H | Regenaplex Nr. 24b | 15 ml | PA | PA | k.A. | | Tropfen zum Einnehmen: 10 Wirkstoffe | Regena AG | D | FB | | G |  |